1. Home
  2. WIA vs QNCX Comparison

WIA vs QNCX Comparison

Compare WIA & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Inflation-Linked Income Fund

WIA

Western Asset Inflation-Linked Income Fund

HOLD

Current Price

$7.99

Market Cap

191.5M

Sector

Finance

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$0.10

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIA
QNCX
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.5M
167.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
WIA
QNCX
Price
$7.99
$0.10
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$10.00
AVG Volume (30 Days)
56.1K
16.2M
Earning Date
01-01-0001
05-12-2026
Dividend Yield
12.29%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.97
$0.08
52 Week High
$8.54
$4.55

Technical Indicators

Market Signals
Indicator
WIA
QNCX
Relative Strength Index (RSI) 26.50 29.94
Support Level N/A $0.09
Resistance Level $8.31 $0.98
Average True Range (ATR) 0.06 0.01
MACD -0.01 0.06
Stochastic Oscillator 17.02 66.12

Price Performance

Historical Comparison
WIA
QNCX

About WIA Western Asset Inflation-Linked Income Fund

Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: